Thomas DiRaimondo
Hoofd Techniek/Wetenschap/O&O bij JANUX THERAPEUTICS, INC.
Vermogen: 5 M $ op 30-04-2024
Profiel
Thomas DiRaimondo is the founder of Sitari Pharma, Inc. (founded in 2013).
He is currently working as the Chief Scientific Officer at Janux Therapeutics, Inc. since 2018.
Dr. DiRaimondo has a doctorate degree from Stanford University and undergraduate and graduate degrees from the University of Michigan.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
JANUX THERAPEUTICS, INC.
0.20% | 02-01-2024 | 101 532 ( 0.20% ) | 5 M $ | 30-04-2024 |
Actieve functies van Thomas DiRaimondo
Bedrijven | Functie | Begin |
---|---|---|
JANUX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2018 |
Eerdere bekende functies van Thomas DiRaimondo
Bedrijven | Functie | Einde |
---|---|---|
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Oprichter | 01-08-2019 |
Opleiding van Thomas DiRaimondo
Stanford University | Doctorate Degree |
University of Michigan | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
JANUX THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Health Technology |